COVID-19 alert: Read about changed restrictions for businesses in Greater Brisbane from 6pm, Monday 11 January.
Subtropical grass pollen allergy diagnostic and immunotherapy
Grass pollens are a major cause of hay fever and allergic asthma globally. Queensland University of Technology (QUT) researchers have developed a high throughput diagnostic test for clinically important allergies to subtropical Bahia and Johnson grass pollen. They are also developing an immunotherapy (desensitisation treatment) for the regulation of the allergic response.
Patients with allergies will more easily determine the specific causes of their allergy and seek out appropriate treatment. The novel immunotherapy may offer more targeted and effective relief to allergy sufferers.
Unique selling point/competitive advantage
The diagnostic test would be the first available standardised test for Bahia and Johnson grass allergy that offers high confidence with outstanding specificity and sensitivity.
The defined allergen components of Bahia and Johnson grass pollen offer improvements over whole pollen extract based therapies.
Investment or collaboration opportunities
QUT bluebox seeks an industry partner to collaborate and develop the technology.
Intellectual property rights
The intellectual property is protected by national phase patent applications in Australia, Europe and the US.
Contact
Andrew Leech
General Manager, Commercial Operations
Email: a.leech@qutbluebox.com.au
More information
Visit QUT bluebox for more information.
Also consider...
- Read about other investment-ready opportunities.
- Discover other collaboration opportunities.
- Last reviewed: 17 Jul 2019
- Last updated: 30 May 2018